Quantitative whole-body autoradiography, LC-MS/MS and MALDI for drug-distribution studies in biological samples: The ultimate matrix trilogy

Bioanalysis

Volumn 6, Issue 3, 2014, Pages 377-391

  McEwen, Andrew B ^a   Henson, Claire M ^a   Wood, Stuart G ^a  

^a Quotient Bioresearch Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE;

DRUG CONCENTRATION; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FECES LEVEL; DRUG METABOLISM; DRUG TISSUE LEVEL; DRUG URINE LEVEL; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; LIQUID SCINTILLATION COUNTING; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; QUANTITATIVE STUDY; REVIEW; SENSITIVITY ANALYSIS; WHOLE BODY AUTORADIOGRAPHY;

ANIMALS; AUTORADIOGRAPHY; CHROMATOGRAPHY, LIQUID; HUMANS; PHARMACEUTICAL PREPARATIONS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; WHOLE-BODY IRRADIATION;

EID: 84893355614     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.336     Document Type: Review

References (47)

1. Wöhler F, Frerichs FT. Concerning the modifications which particular organic materials undergo in their transition to the urine. Ann. Chem. Pharm. 63, 335 (1848
2. Ure A. On gouty concretions; with a new method of treatment. Med. Chir. Trans. 24, 30-35 (1841
3. Keller W. On the conversion of benzoic acid into hippuric acid. Ann. Chem. Pharm. 43, 108 (1842
4. Marchand RF. Metabolism of cinnamic acid to hippuric acid in animals. Ann. Chem. Pharm. 44, 344 (1842
5. Schultzen O, Naunyn B. The behaviour of benzene-derived hydrocarbons in the animal organism. Arch. Anat. Physiol. 349 (1867
6. Hill H. Development of bioanalysis: A short history. Bioanalysis 1(1), 3-7 (2009
7. US Department of Health and Human Services Food and Drug Administration, US FDA, Center for Drug Evaluation and Research, Pharmacology and Toxicology. Guidance for Industry, Safety Testing of Drug Metabolites. US FDA, Rockville, MD, USA (2008
8. European Medicines Agency. ICH Topic M 3 (R2) Non-Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals (CPMP/ICH/286/95). European Medicines Agency, London, UK (2009
9. Baillie T, Cayen MN, Fouda H et al. Drug metabolites in safety testing. Toxicol. Appl. Pharmacol. 182, 188-196 (2002
10. Smith D, Obach RS. Seeing through the MIST: Abundance versus percentage. Commentary on metabolites in safety testing. Drug Metab. Dispos. 33, 1409-1417 (2005
11. Waters NJ, Lombardo F. Use of the ole-Tozer model in understanding mechanisms and determinants of drug distribution. Drug Metab. Dispos. 38, 1159-1165 (2010
12. International Transporter Consortium, Giacomini KM, Huang SM et al. Membrane Transporters in Drug Development. Nat. Rev. Drug Discov. 9, 215-236 (March 2010
13. De Buck SS, Sinha VK, Fenu LA, Gilissen RA, Mackie CE, Nijsen MJ. The prediction of drug metabolism, tissue distribution and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools. Drug Metab. Dispos. 35, 649-659 (2007
14. Ullberg S. Studies on the distribution and fate of 35S-labelled benzylpenicillin in the body. Acta Radiologica Suppl. 118, 1-110 (1954
15. Ullberg S. The technique of whole body autoradiography cryosectioning of large specimens. Science Tools, The LKB Instrument Journal 1-29 (1977
16. Wang L, He K, Maxwell B et al. Tissue distribution and elimination of [14C]Apixaban in rats. Drug Metab. Dispos. 39, 256-264 (2011
17. Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA. Drug-protein adducts: An industry perspective on minimising the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 17, 3-16 (2004
18. Walgren JL, Mitchell MD, Thompson DC. Role of metabolism in drug-induced idiosynchratic hepatotoxicity. Crit. Rev. Toxicol. 35, 325-361(2005
19. Zhou S, Chan E, Duan W, Huang M, Chen YZ. Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab. Rev. 37, 41-213 (2005
20. Baillie TA, Davis MR. Mass spectrometry in the analysis of glutathione conjugates. Biol. Mass Spectrom. 22, 319-325 (1993
21. Masabuchi N, Makino C, Murayama N. Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediates and in vitro glutathione conjugate formation in rats and humans. Chem. Res. Toxicol. 20, 455-464 (2007
22. Gan J, Harper TW, Hsueh MM, Qu Q, Humphreys WG. Dansyl glutathione as a trapping agent for quantitative estimation and identification of reactive metabolites. Chem. Res. Toxicol. 18, 896-903 (2005
23. Takakusa H, Masamuto H, Yukinaga H et al. Covalent binding and tissue distribution/retention assessment of drugs associated with idiosyncratic drug toxicity. Drug Metab. Dispos. 36, 1770-1779 (2008
24. Zhang J, Tao F, Li Y et al. Pharmacokinetics, tissue distribution and oral bioavailability evaluation of isoimperotorin by high performance liquid chromatography coupled with mass spectrometry. J. Med. Plant Res. 6, 1721-1729 (2011
25. Drexler DM, Garrett TJ, Cantone JL et al. Utility of imaging mass spectrometry (IMS) by matrix-Assisted laser desorption ionisation (MALDI) on an ion trap mass spectrometer in the ana¬lysis of drugs and metabolites in biological tissues. J. Pharmaol. Toxicol. Methods 55(3), 279-288 (2007
26. Barroso ML, King KW, Tran C, Shen A, Zhang X. Case studies of accurate measurement of small molecule drugs in various tissues: Knowledge versus assumption. American Society for Mass Spectrometry, CO, USA (2008
27. Xue Y-J, Gao H, Li QC et al. Bioanalysis of drug in tissue: Current status and challenges. Bioanalysis 4(21), 2637-2653 (2012
28. Schadt S, Kallbach S, Almeida R, Sandel J. Investigation of figopitant and its metabolites in rat tissue by combining whole-body autoradiography with liquid extraction surface analysis mass spectrometry. Drug Metab. Dispos. 40, 419-425 (2012
29. Langer O, Muller M. Methods to assess tissue-specific distribution and metabolism of drugs. Curr. Drug Metab. 5(6), 463-481(2004
30. Want EJ, Masson P, Michopolous F et al Global metabolic profiling of animal and human tissues via UPLC-MS. Nature Protoc. 8(1), 17-32 (2013
31. Karas M, Bachmann D, Hillenkamp F. Influence of the wavelength in high-irradiance ultraviolet laser desorption mass spectrometry of organic molecules. Anal. Chem. 57(14), 2935-2939 (1985
32. Troendle FJ, Reddick CD, Yost RA. Detection of pharmaceutical compounds in tissue by matrix-Assisted laser desorption/ionisation tandem mass spectrometry with a quadropole ion trap. J. Am. Soc. Mass Spectrom. 10, 1315-1321 (1999
33. Rohner TC, Staab D, Stoeckli M. MALDI mass spectrometric imaging of biological tissue sections. Mech. Ageing Dev. 126, 177-185 (2005
34. Stoeckli M, Staab D, Schweizer A. Compound and metabolite distribution measured by MALDI mass spectrometric imaging in whole body tissue sections. J. Mass Spectrom. 260, 195-202 (2007
35. Khatib-Shahidi S, Andersson M, Herman JL, Gillespie TA, Caprioli RM. Direct molecular ana¬lysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal. Chem. 78(18) 6448-6456 (2006).
36. Castellino S, Groseclose MR, Wagner D. MALDI imaging mass spectrometry: Bridging biology and chemistry in drug development. Bioanalysis 3(21), 2427-2441 (2011
37. Annesly T. Ion suppression in mass spectrometry. Clin. Chem. 49(7), 1041-1044 (2003
38. Seeley EH, Caprioli RM. Molecular imaging of proteins in tissues by mass spectrometry. Proc. Natl Acad. Sci. USA 105(47), 18126-18131 (2008
39. Yamaguchi S, Fujita T, Fujino T, Korenaga T. Suppression of matrix-related ions using cyclodextrin in MALDI mass spectrometry. Anal. Sci. 24, 1497-1500 (2008
40. Nillson A, Fehniger TE, Gustavsson L et al. Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry. PloS ONE 5(7), e11411 (2010
41. Koeniger SL, Talaty N, Luo Y et al. A quantitation method for mass spectrometry imaging. Rapid Commun. Mass Spectrom. 25, 503-510 (2011
42. Schweitzer A, Fahr A, Neideberger W. A simple method for the quantitation of 14C-whole-body autoradiograms. Int. J. Rad. Appl. Instrum. 38(5), 329-333 (1987
43. Trim PJ, Henson CM, Avery JL et al. Matrix-Assisted laser desorption/ionisation-ion mobility separation-mass spectrometry imaging of vinblastine in whole body tissue sections. Anal. Chem. 80, 8628-8634 (2008
44. Van Berkel GJ, Kertesz V. Application of a liquid extraction based sealing surface sampling probe for mass spectrometric ana¬lysis of dried blood spots and mouse whole-body thin tissue sections. Anal. Chem. 81(21), 9146-9152 (2009
45. Eikel D, Vavrek M, Smith S et al. Liquid extraction surface ana¬lysis mass spectrometry (LESA-MS) as a novel profiling tool for drug distribution and metabolism ana¬lysis: The terfenadine example. Rapid Commun. Mass Spectrom. 25, 3587-3596 (2011
46. Parson WB, Koeniger SL, Johnson RW et al. Analysis of chloroquine and metabolites directly from whole-body animal tissue sections by liquid extraction surface analysis (LESA) and tandem mass spectrometry. J. Mass Spectrom. 47, 1420-1428 (2012
47. Xia B, Heimbach T, Lin T, He H, Wang Y, Tan E. Novel physiologically based pharmacokinetic modelling of patupilone for human pharmacokinetic predictions. Cancer Chemother. Pharmacol. 69(6), 1567-1582 (2012).